Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Pre-Operative Docetaxel-Cytoxan (TC) in Patients With Hormone Receptor-Positive Cancers With Recurrence Scores ≥ 25

NCT00832338 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT00832338
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00832338 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Pre-Operative Docetaxel-Cytoxan (TC) in Patients With Hormone Receptor-Positive Cancers With Recurrence Scores ≥ 25
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2009
Completion date
October 31, 2015
Enrollment
23 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms, cancer of the breast